• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Avoiding the Telemedicine Cliff: Why the DEA Extended Prescribing Rules Through 2026

by Fred Pennic 01/02/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
HHS Launches EHR Innovations for Improving Hypertension Challenge_HHS Funded Health Care Innovation Award Projects to Watch

What You Should Know: 

– In a significant move for the “tele-prescribing” landscape, the U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have announced a fourth temporary extension of telemedicine flexibilities. 

– This extension allows practitioners to prescribe controlled medications—including Schedule II–V drugs—via audio-video encounters without a prior in-person medical evaluation through December 31, 2026.

A Transitional Safety Net

 The policy is a critical “lifeline” for roughly 7 million Americans who received remote prescriptions for controlled substances in 2024 alone. This fourth extension is less about a final decision and more about managing “regulatory debt.” By pushing the deadline to the end of 2026, the administration is buying time to finalize a permanent Special Registration for Telemedicine framework. 

The “Special Registration” Horizon

The DEA is using this extension to refine a “Special Registration” that would likely require:

  • Identity Verification: Use of state/federal government ID to verify patient identity during the tele-treatment.
  • PDMP Checks: Mandatory review of Prescription Drug Monitoring Program data before any remote prescription is issued.
  • Recordkeeping: Detailed documentation of “legitimate medical purpose” for Schedule II medications, which remain the highest-risk category for diversion.

While the extension provides “breathing room,” practitioners must stay vigilant about state-level laws, which are not preempted by this federal extension. In some jurisdictions, state-specific in-person requirements may still apply despite this federal “green light.”

“Telehealth prescribing flexibilities have become a lifeline for millions of Americans,” said HHS Deputy Secretary Jim O’Neill. “Extending them ensures continuity of care while we finish the work of putting permanent, commonsense policies in place. This action protects patients, preserves access, and maintains strong controls against diversion.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |